Related Experiment Video
Updated: May 17, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
[Control of myocardial ischemia in patients with effort angina and polyvascular atherosclerotic involvement]
Insights
Effective treatment for ischemic heart disease involves using cardioselective beta-blockers to manage arterial pressure and heart rate. Additional medications like calcium antagonists and ACE inhibitors can further control myocardial ischemia in daily life.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Ischemic heart disease (IHD) often coexists with peripheral artery atherosclerosis.
- Managing cardiovascular risk factors is crucial in IHD patients.
Purpose of the Study:
- To evaluate a therapeutic strategy for IHD patients with peripheral artery disease.
- To assess the control of myocardial ischemia and heart rate in daily life.
Main Methods:
- Therapy included cardioselective beta-blockers as the primary choice.
- Calcium antagonists and angiotensin-converting enzyme inhibitors were added as needed.
- Focus on maintaining target arterial pressure and heart rate levels.
Main Results:
- The described therapeutic approach successfully controlled myocardial ischemia.
- Target heart rate levels were effectively maintained under everyday conditions.
- Arterial pressure management was achieved in patients with IHD and peripheral artery atherosclerosis.
Conclusions:
- Cardioselective beta-blockers, with potential additions, are effective for managing IHD.
- This strategy aids in controlling myocardial ischemia and heart rate in patients with concurrent peripheral artery disease.
- Achieving target blood pressure and heart rate is feasible in daily life for this patient group.
Abstract:
In patients with ischemic heart disease with various degree of severity of atherosclerotic involvement of peripheral arteries maintenance of target levels of arterial pressure and heart rate with the help of therapy which includes cardioselective -adrenoblocker as a preparation of choice with addition if necessary of a calcium antagonist and angiotensin converting enzyme inhibitor allows to successfully control myocardial ischemia and heart rate under conditions of everyday life.
Related Concept Videos
Angina IV: Management
Angina V: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Acute Coronary Syndrome IV: Interprofessional Care
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...

